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Abstract
Background: We report an extremely rare case of concomitant huge exophytic GIST of the
stomach and Kasabach-Merritt phenomenon (KMP).
Case presentation: The patient was a 67-year-old man experiencing abdominal distension since
September 2006. A physical examination revealed a 25 × 30 cm hard mass that was palpable in the
middle and lower left abdomen minimal intrinsic mobility and massive ascites. Since the admitted
patient was diagnosed with DIC, surgery could not be performed. The patient received a platelet
transfusion and the DIC was treated. Due to this treatment, the platelet count recovered to 7.0 ×
104; tumor resection was performed at 16 days after admission. Laparotomy revealed a huge
extraluminal tumor arising from the greater curvature of the stomach that measured 25 × 30 cm
and had not ruptured into the peritoneal cavity or infiltrated other organs. Partial gastric resection
was performed. The resected mass measured 25 × 25 × 20 cm. In cross section, the tumor
appeared hard and homogenous with a small polycystic area. Histopathology of the resected
specimen showed large spindle cell GIST with >5/50 HPF (high-power field) mitotic activity. The
postoperative course was uneventful, and the coagulopathy improved rapidly.
Conclusion: Since the characteristic of tumor in this case was hypervascularity with bleeding and
necrotic lesions, coagulopathy was thought to be caused by the trapping of platelets within a large
vasculized tumor mass.
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Background
Gastrointestinal stromal tumors (GISTs) are mesenchy-
mal tumors of the digestive tract with various clinical and
biological characteristics. The expression of c-kit distin-
guishes GISTs from true leiomyomas, leiomyosarcomas,
and other mesenchymal tumors of the GI tract [1-3]. The
stomach (60%–70%) and small intestine (20%–30%) are
the most common sites for GISTs [1,2].
An association between a vascular lesion and life-threat-
ening coagulopathy is termed as the Kasabach-Merritt
phenomenon (KMP). It includes thrombocytopenia,
microangiopathic hemolytic anemia, and disseminated
intravascular coagulopaty (DIC). Generally, KMP is the
most characteristic symptom of giant hemagiomas [4-7].
To our knowledge, no case of concomitant GIST and KMP
has been reported thus far. Here, we report an extremely
rare case of concomitant huge exophytic GIST of the stom-
ach and KMP.
Case presentation
The patient was a 67-year-old man experiencing abdomi-
nal distension since September 2006. In October 2006,
the abdominal fullness became progressive, and he had
hard general fatigue. There was no history of vomiting,
fever, or gastrointestinal bleeding. Renal failure occurred
due to diabetes mellitus (DM). On admission in Novem-
ber 2006, a physical examination revealed a 25 × 30 cm
hard mass that was palpable in the middle and lower left
abdomen minimal intrinsic mobility and massive ascites.
An upper gastrointestinal barium study and gastric endo-
scopic examination indicated no anomalies. Tumor find-
ings of Doppler ultrasonography showed a hypoechoic
lesion with a hypervascular area (Figure 1). An abdominal
computed tomography (CT) scan showed a huge hetero-
geneous mass sized 20 × 25 cm extending from the greater
curvature of the middle body of the stomach (Figure 2).
Abdominal magnetic resonance imaging (MRI) was per-
formed, and almost the entire abdominal cavity was visu-
alized in the coronal view. The irregular wall of the lesion
exhibited a low intensity signal on the T1-weihted image
and a high-intensity signal on the T2-weighted image (Fig-
ure 3).
Routine biochemical investigation revealed hypoalbu-
minemia, renal dysfunction, and hyperglycemia. Since the
admitted patient was diagnosed with DIC (platelet count:
2000 mm3, FDP: 135.4 µg/ml, PT: 1.20, SIRS score: over
3 heads) surgery could not be performed. The patient
received a platelet transfusion of 20 units each day 6
times, and the DIC was treated with nafamostat mesilate
and fresh-frozen plasma. Due to this treatment, the plate-
let count recovered to 7.0 × 104; tumor resection was per-
formed at 16 days after admission. Laparotomy revealed a
huge extraluminal tumor arising from the greater curva-
ture of the stomach that measured 25 × 30 cm and had not
ruptured into the peritoneal cavity or infiltrated other
organs (Figure 4A). An attaching pedicle approximately 3
cm in breadth was observed in the greater curvature of
middle body of the stomach. Partial gastric resection was
performed (Figure 4A).
The resected mass measured 25 × 25 × 20 cm. In cross sec-
tion, the tumor appeared hard and homogenous with a
small polycystic area (Figure 4B). Histopathology of the
resected specimen showed large spindle cell GIST with >5/
50 HPF (high-power field) mitotic activity (Figure 5A).
No evidence of infiltration was observed in the resected
margins of the stomach wall. Immunohistochemical
staining was strongly positive for CD34 and CD117 (Fig-
ure 5B and 5C), and negative for α-SMA, S-100 and
Desmin.
Abdominal computed-tomography shows a huge heterogene- ous mass with a thick and irregular wall sized 20 × 25 cm  extending from the greater curvature of the middle of the  stomach Figure 2
Abdominal computed-tomography shows a huge heterogene-
ous mass with a thick and irregular wall sized 20 × 25 cm 
extending from the greater curvature of the middle of the 
stomach.
Doppler ultrasonography shows hypervascular area in the  tumor Figure 1
Doppler ultrasonography shows hypervascular area in the 
tumor.World Journal of Surgical Oncology 2007, 5:59 http://www.wjso.com/content/5/1/59
Page 3 of 4
(page number not for citation purposes)
The postoperative course was uneventful, and the coagu-
lopathy improved rapidly. The patient was carefully fol-
lowed up regularly. Imatinib mesylate (Gleevec™/Novartis
Pharma AG, Basel, Switzerland) was administered orally
300 mg per day because the patient displayed renal dys-
function (serum creatinine: 3.98, blood urea nitrogen
(BUN): 41.5)
Discussion
The definition of a GIST has been changing with immuno-
histochemical and molecular technical advances [8]. It is
widely accepted that a GIST is a mesenchymal tumor that
expresses the c-kit oncoprotein or has a mutation in either
the c-kit or the platelet-derived growth factor receptor-alfa
(PDGFRA) gene [9]. Several studies have revealed various
types of c-kit mutations, including mutations in the jux-
tamembrane (exon 11), extracellular (exon 9), and tyro-
sine kinase (exon 13 and 17) domains [9].
Fletcher et al., reported a classification for malignancies
that is based on tumor size and the number of mitotic
divisions [10]. They classified gastric GISTs into the fol-
lowing four groups: very low risk (<2 cm in size and
<mitoses5/50 HPF), low risk (2~5 cm and < mitoses 5/50
HPF), intermediate risk (<5 cm and < mitoses/50 HPFs or
5–10 cm and <5/50 HPF), high risk (>5 cm and >5/50
HPF or >10 cm and any mitoic rate or any size and >10/
50 HPF). According to this classification, our case was
classified as high risk. Moreover, Carrillo et al., reported
that a high MIB-1 index (>22%, in the most active area)
was the most powerful predictor of poor survival [11]. The
highest MIB-1 index value for the present patient was
28%, suggesting the malignant nature of the tumor.
The designation of KMP has been applied to cases in
which vascular lesions occur in association with profound
thrombocytopenia and hypofibrogenemia with fibrin
degradation products. It is important to rule out visceral
lesions in the liver, spleen, and retroperitoneum, and
hematologic malignancies such as leukemia and other
malignancies that can cause a similar cutaneous presenta-
tion such as neuroblastoma [12]. The disseminated intra-
vascular coagulation is caused by an activation of the
clotting cascade and the formation of intravascular fibrin,
and can results in microangiopathic hemolysis and occa-
sionally red cell fragmentation seen on the peripheral
blood smear [13]. Since the characteristic of tumor in this
case was hypervascularity with bleeding and necrotic
lesions, coagulopathy was thought to be caused by the
trapping of platelets within a large vasculized tumor mass.
Only a few reports described the coincidence of consump-
tion coagulopathy and angiomatous tumor associated
with KMP in the adulthood [7,15]. Moreover, although
KMP is believed to be caused by clotting and fibrinolysis
Photomicrograph showing Figure 5
Photomicrograph showing A). Microscopically, the tumor 
was characterized by fascicular and interlacing proliferation 
of the spindle-shaped cells.(Hematoxylin and Eosin × 200) B). 
Histopathology slide after Immunostaining for CD34: Tumor 
cell show positivity after CD34 staining. C) Histopathology 
slide after Immunostaining for CD117: Tumor cell show pos-
itivity after CD117 staining.
Abdominal MRI shows huge inhomogeneous mass lesion can  be identified in the right side of the intra-abdomen Figure 3
Abdominal MRI shows huge inhomogeneous mass lesion can 
be identified in the right side of the intra-abdomen.
A and B) huge solid tumor arising from the greater curvature  of the stomach that measured 25 × 25 cm and had not rup- tured into the peritoneal cavity or infiltrated other organs Figure 4
A and B) huge solid tumor arising from the greater curvature 
of the stomach that measured 25 × 25 cm and had not rup-
tured into the peritoneal cavity or infiltrated other organs. 
An attaching pedicle approximately 3 cm in breadth was 
observed in the greater curvature of middle body of the 
stomach. Partial gastric resection was performed. C and D) 
The resected mass measured 25 × 25 × 20 cm. In cross sec-
tion, the tumor appeared hard and homogenous with a small 
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within giant hemangiomas and despite several cases of
giant GIST of the stomach being reported, no case of con-
comitant gastric GIST and KMP has been reported thus far
[8]. Because the predisposition to bleeding (observed in
KMP) is the primary cause of death, aggressive treatment
is required.
Imatinib mesylate, which is a competitive inhibitor of cer-
tain tyrosine kinases including intracellular kinases ABL
and the BCR-ABL fusion proteins present in some leuke-
mias, and PDGFRA, is the first effective drug for GIST
[[16,17], 18]. The use of Gleevec as an adjuvant is cur-
rently being explored with on going randomized phase III
trials.
Conclusion
Since the characteristic of tumor in this case was hypervas-
cularity with bleeding and necrotic lesions, coagulopathy
was thought to be caused by the trapping of platelets
within a large vasculized tumor mass.
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